Event Date/Time: Feb 11, 2010 End Date/Time: Feb 11, 2010
Registration Date: Feb 10, 2010
Report as Spam


Technology, reform and innovation are driving significant changes in how healthcare is delivered. The pharma industry will play a crucial role in shaping this, but will need to innovate to stay ahead.

Now in its 16th year, The Pharma Summit is the strategic forum to understand how firms can take advantage of these developments and drive future competitive advantage. Taking place in London on February 11th 2010, the event will bring together 150 senior executives from across pharma including some of the industry's most influential names.

GET INSIGHT FROM THREE OF THE INDUSTRY'S LEADING CHIEF EXECUTIVES: hear their unique visions for the future of pharma

DISCOVER HOW BUSINESS MODELS ARE CHANGING to reflect the innovation in healthcare delivery

LEARN ABOUT THE EVOLVING CUSTOMER from other industries and how patients are now driving changes

DISCOVER NEW HEALTHCARE TECHNOLOGIES: understand the challenges and opportunities that it offers pharma

HEAR THE ECONOMIST INTELLIGENCE UNIT'S LATEST FORECAST: for the markets that will lead the industry's growth in 2010

FIND OUT ABOUT THE FUTURE OF INNOVATION IN PHARMA and how biohackers can change the way the industry innovates

Superb speakers will include:

- David Brennan, Chief Executive Officer, AstraZeneca
- Roch Doliveux, Chief Executive Officer and Chairman of the Executive Committee, UCB
- Paul Stoffels, Company Group Chairman, Research & Development, Johnson & Johnson Pharmaceuticals Group
- Ulf Wiinberg, President and Chief Executive Officer, H. Lundbeck
- Werner Cautreels, Chief Executive Officer, Solvay Pharmaceuticals
- Jon Achenbaum, Senior Vice-president Global Strategic Marketing, Bayer HealthCare Diabetes Care
- Ornella Barra, Chief Executive of the Pharmaceutical Wholesale Division, Alliance Boots
- Jeff George, Chief Executive Officer, Sandoz
- Ranjit Shahani, Country President, Novartis India
- Patrick Flochel, Partner, EMEIA Life Sciences Leader, Ernst & Young